Research and Markets has announced the addition of the "Global Pharmerging Markets 2017-2021" report to their offering.
The global pharmerging market to grow at a CAGR of 12.88% during the period 2017-2021.
The immense growth potential in pharmerging market has driven large multinational pharmaceutical companies to focus on these regions by pursuing organic as well as in-organic routes. To make in-roads into the new geography, the large players usually take in-organic route through strategic expansion initiatives such as acquisitions and alliances. For instance, in December 2015, AstraZeneca entered into a deal with WuXi to acquire its biologics manufacturing facilities in China to expand locally.
Global Pharmerging Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors
- AstraZeneca
- GlaxoSmithKline
- Pfizer
- Sanofi
-
Novartis
Other prominent vendors
- Abbott Laboratories
- AbbVie
- Alexion Pharmaceuticals
- Allergan
- Amgen
- Aspen
- Astellas Pharma
- Baxter
- Bayer
- Biogen
- Boehringer Ingelheim
- Bristol-Myers Squibb
- Celgene
- Eli Lilly
- Takeda Pharma
- Teva Pharmaceutical Industries
- UCB
- Valeant Pharmaceuticals
-
Others
Key Topics Covered:
Part 01: Executive summary
Part 02: Scope of the report
Part 03: Market research methodology
Part 04: Introduction
Part 05: Global pharmaceutical market
Part 06: Road to pharmerging markets
Part 07: Pharmerging markets
Part 08: Market landscape
Part 09: Market segmentation by geography
Part 10: Market overview of tier I countries
Part 11: Market overview of tier II countries
Part 12: Market overview of tier III countries
Part 13: Market drivers
Part 14: Impact of drivers
Part 15: Market challenges
Part 16: Impact of drivers and challenges
Part 17: Market trends
Part 18: Vendor landscape
Part 19: Key vendor analysis
Part 20: Appendix
For more information about this report visit http://www.researchandmarkets.com/research/sk9knv/global
View source version on businesswire.com: http://www.businesswire.com/news/home/20170125005763/en/